You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

SODIUM TETRADECYL SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Tetradecyl Sulfate, and what generic alternatives are available?

Sodium Tetradecyl Sulfate is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in SODIUM TETRADECYL SULFATE is sodium tetradecyl sulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Tetradecyl Sulfate

A generic version of SODIUM TETRADECYL SULFATE was approved as sodium tetradecyl sulfate by HIKMA on December 9th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM TETRADECYL SULFATE?
  • What are the global sales for SODIUM TETRADECYL SULFATE?
  • What is Average Wholesale Price for SODIUM TETRADECYL SULFATE?
Drug patent expirations by year for SODIUM TETRADECYL SULFATE
Recent Clinical Trials for SODIUM TETRADECYL SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Goldman, Butterwick, Fitzpatrick and GroffPhase 2
Combined Military Hospital, PakistanEarly Phase 1
Oulu University HospitalN/A

See all SODIUM TETRADECYL SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for SODIUM TETRADECYL SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM TETRADECYL SULFATE

US Patents and Regulatory Information for SODIUM TETRADECYL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma SODIUM TETRADECYL SULFATE sodium tetradecyl sulfate INJECTABLE;INJECTION 209937-001 Dec 9, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.